CM
BNTX icon

Caption Management’s BioNTech BNTX Stock Holding History

Caption Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
+20,000
New +$1.88M 0.01% 928
2025
Q1 		– Sell
-25,000
Closed -$2.85M – 1546
2024
Q4 		$2.85M Buy
+25,000
New +$2.85M 0.03% 570

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Caption Management's BNTX Position: Q2 2026 in Review

Caption Management increased its BioNTech (BNTX) stake by 165% in Q2 2026, buying an estimated $701K and bringing the position to 11,946 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #1099.

Caption Management first reported a position in BNTX in Q2 2020 and has held it in 7 quarters since. The position peaked at $1.12M in Q2 2020. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Caption Management held 11,946 shares of BioNTech worth $1.11M as of Q2 2026.
  • Caption Management bought 7,446 BioNTech shares in Q2 2026, an estimated $701K.
  • BioNTech made up 0.01% of Caption Management's portfolio in Q2 2026, its #1099 holding.
  • Caption Management first reported a position in BioNTech in Q2 2020 and has held it in 7 quarters since.
  • Caption Management's BioNTech position peaked at $1.12M in Q2 2020.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.